🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Some breast cancer cells make a protein called Human Epidermal Growth facto...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-11-06
Trial ID
NCT02286843
Treatments Being Tested
This is an open-label, single center, pilot study to assess the feasibility...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-31
Trial ID
NCT04757090
Treatments Being Tested
Information about the presence of human epidermal growth factor receptor 2 ...
Status
Completed
Location
University Medical Center
Start Date
2013-03
Trial ID
NCT01832051
Treatments Being Tested
ZEPHIR-02 is a multicentre, open-label phase II study that will enroll subj...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2026-06-30
Trial ID
NCT06595563
Treatments Being Tested
The purpose of the first group (Group 1) was to find the optimal time for t...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-12
Trial ID
NCT02023996
Treatments Being Tested
A strategy to target the oncogenic receptor HER2 using a version of the ant...
Status
Recruiting
Location
Centre de recherche du CHUS
Start Date
2024-12-01
Trial ID
NCT06732336
Treatments Being Tested
The investigators investigate whether PET imaging with ⁸⁹Zr-trastuzumab can...
Status
Not Yet Recruiting
Location
The Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2026-09-07
Trial ID
NCT07436858
Treatments Being Tested
Current patient work-up, including conventional imaging and pathological as...
Status
Active Not Recruiting
Location
VU University Medical Center
Start Date
2013-08-30
Trial ID
NCT01957332
Treatments Being Tested
T-DM1 , which is a highly innovative but also expensive antiHER2 agent cons...
Status
Completed
Location
Universitair Ziekenhuis Antwerpen (UZA)
Start Date
2012-05
Trial ID
NCT01565200
Treatments Being Tested
Evaluation of the diagnostic potential of HER2 imaging using zirconium 89 l...
Status
Completed
Location
Jules Bordet Institut
Start Date
2011-08
Trial ID
NCT01420146
Treatments Being Tested